Virios Therapeutics (NASDAQ: VIRI) Advances Promising Antiviral Therapies for Chronic Diseases: Latest Momentum and Pipeline Developments
Virios Therapeutics, Inc. (NASDAQ: VIRI), a biotechnology company focused on advancing groundbreaking antiviral treatments for chronic conditions like fibromyalgia and Long-COVID, has experienced significant momentum over the past six months. At its peak, the company's stock surged by over 600%. While recent market fluctuations have caused a dip from these record highs, Virios is once
Source: microcapdaily.com